Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) and the associated coronavirus disease 2019 (COVID-19) continue to spread throughout the world, causing more than 120 million infections. Several variants of concern (VOCs) have emerged and spread with implications for vaccine effi...
Main Authors: | Marco Fabiani, Katia Margiotti, Antonella Viola, Alvaro Mesoraca, Claudio Giorlandino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/5/614 |
Similar Items
-
Evaluation of SARS-CoV-2 viral RNA in fecal samples
by: Alvaro Mesoraca, et al.
Published: (2020-06-01) -
Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients
by: Claudia Maria Trombetta, et al.
Published: (2021-07-01) -
An Autochthonous Outbreak of the SARS-CoV-2 P.1 Variant of Concern in Southern Italy, April 2021
by: Daniela Loconsole, et al.
Published: (2021-08-01) -
Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation
by: Ismail Celik, et al.
Published: (2021-09-01) -
Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics
by: Corinna Ernst, et al.
Published: (2018-03-01)